Futura Medical plc announced the appointment of Ken James, the former head of consumer healthcare R&D at GlaxoSmithKline plc (GSK), as a Non-Executive Director, with effect from 31 March 2016. Mr. James has more than 40 years' experience of healthcare R&D, having joined one of GSK's predecessor businesses, Beecham Products, in 1973. Mr. James recently retired from GSK.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
39.35 GBX | +1.16% | -0.88% | +54.31% |
Apr. 10 | Futura Medical hails results as erectile dysfunction drug drives sales | AN |
Apr. 10 | Transcript : Futura Medical plc, 2023 Earnings Call, Apr 10, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+54.31% | 149M | |
+8.62% | 114B | |
+10.55% | 104B | |
-12.63% | 22.41B | |
-0.44% | 22.28B | |
-5.75% | 19.07B | |
-37.36% | 18B | |
-5.59% | 17.89B | |
+6.97% | 14.28B | |
+37.10% | 12.55B |
- Stock Market
- Equities
- FUM Stock
- News Futura Medical plc
- Futura Medical plc Appoints Ken James as Non-Executive Director, Effective from 31 March 2016